Skip to main content Skip to navigation

Association For Multiple Endocrine Neoplasia Disorders

Also known as: Amend

AMEND PROVIDES SUPPORT AND INFORMATION TO PATIENTS FAMILIES AND CARERS AFFECTED BY THE RARE GENETIC DISORDERS MULTIPLE ENDOCRINE NEOPLASIA, AS WELL AS TO THOSE WITH ASSOCIATED FAMILIAL AND SPORADIC TUMOURS. AMEND AIMS TO PROMOTE GREATER KNOWLEDGE OF THE BEST CARE AND MANAGEMENT OF MEN AND ASSOCIATED TUMOUR PATIENTS AMONGST THE MEDICAL PROFESSION.

Contact Charity

Activities & Mission

AMEND PROVIDES SUPPORT AND INFORMATION TO PATIENTS FAMILIES AND CARERS AFFECTED BY THE RARE GENETIC DISORDERS MULTIPLE ENDOCRINE NEOPLASIA, AS WELL AS TO THOSE WITH ASSOCIATED FAMILIAL AND SPORADIC TUMOURS. AMEND AIMS TO PROMOTE GREATER KNOWLEDGE OF THE BEST CARE AND MANAGEMENT OF MEN AND ASSOCIATED TUMOUR PATIENTS AMONGST THE MEDICAL PROFESSION.

Is this your charity?

Add your logo, photos and tell the story behind the numbers in your own words. Free for our first 50 launch partners.

Claim this listing Learn more about premium profiles See a sample profile

Areas of Operation

Where this charity is registered to operate, as self-declared to the Charity Commission. These are regulatory classifications, not a list of active programmes, and don't necessarily indicate fundraising activity in each location.

Financial Information

Latest Income
£82,239
Latest Expenditure
£91,202

Financial Efficiency

Expenditure Ratio 110.9%
Expenditure as % of income

Financial Trend

Annual Returns

As filed with the Charity Commission for England and Wales. Most recent filing covers the financial year ending 2025.

Financial YearIncomeExpenditureCharitable SpendingNet AssetsReservesStaff
2025
£82,239
£91,2020 / 18
2024
£95,173
£106,0160 / 29
2023
£80,668
£112,2920 / 30
2022
£130,264
£139,3970 / 17
2021
£93,239
£129,6370 / 17

Staff column shows: Employees / Volunteers

Frequently asked questions about Association For Multiple Endocrine Neoplasia Disorders

What does Association For Multiple Endocrine Neoplasia Disorders do?

AMEND PROVIDES SUPPORT AND INFORMATION TO PATIENTS FAMILIES AND CARERS AFFECTED BY THE RARE GENETIC DISORDERS MULTIPLE ENDOCRINE NEOPLASIA, AS WELL AS TO THOSE WITH ASSOCIATED FAMILIAL AND SPORADIC TUMOURS. AMEND AIMS TO PROMOTE GREATER KNOWLEDGE OF THE BEST CARE AND MANAGEMENT OF MEN AND ASSOCIATED TUMOUR PATIENTS AMONGST THE MEDICAL PROFESSION.

How much income did Association For Multiple Endocrine Neoplasia Disorders report in 2025?

Association For Multiple Endocrine Neoplasia Disorders reported total income of £82k and reported expenditure of £91k for the financial year ending 2025, based on the most recent annual return filed with the Charity Commission.

When was Association For Multiple Endocrine Neoplasia Disorders registered as a charity?

Association For Multiple Endocrine Neoplasia Disorders was registered with the Charity Commission for England and Wales on 20 September 2013 as charity number 1153890. It has been registered for 13 years.

Who runs Association For Multiple Endocrine Neoplasia Disorders?

Association For Multiple Endocrine Neoplasia Disorders is governed by a board of 11 trustees. Trustees are legally responsible for the charity's governance and are listed in full on its profile.

Where does Association For Multiple Endocrine Neoplasia Disorders operate?

Association For Multiple Endocrine Neoplasia Disorders operates across 3 areas: Northern Ireland, Scotland and England And Wales.

Is Association For Multiple Endocrine Neoplasia Disorders a registered charity?

Yes — Association For Multiple Endocrine Neoplasia Disorders is a registered charity in England and Wales, charity number 1153890.

Details

Contact (address, email, phone)
Registration Date
20 September 2013
Status
Registered

Registry Information

Organisation Number
5041049
Charity Number
1153890

Trustees

Andrew Price
Dr John Ayuk
Gemma Swindells
GILL MASTERS
Graeme Cohen
Lauren Wheeler ACA
Miriam Asia
PROFESSOR KARIM MEERAN
Robert Millinship
Sarah Norman
Shahab Khan

Also Known As

  • Amend

Data & trust

Register data refreshed
19 October 2026
Report a data issue